Injection price
$119/month
Lozenge price
$99 for a 30-day supply
Care
Physician consultations and follow-ups advertised as free
Shipping
Free discreet shipping
Renewal
Auto-refill advertised
Formats
Subcutaneous injection and sublingual lozenge

Two listings deserve two comparisons

Strut Health offers a sermorelin injection and a sublingual lozenge. The product page's broad hero presentation groups the formats under a $119 monthly figure, while its detailed pricing cards distinguish the $119 injection from the $99 oral product. We use those specific cards and keep the products separate. A reader should still confirm the selected format and current charge at checkout rather than assuming the initial page selection carried through.

The difference is more than twenty dollars. Route, supply, administration requirements and supporting evidence need to match the actual prescription.

What is visibly included in the service

The page says its price includes physician consultations and shipping. It also advertises free follow-ups, provider messaging and discreet packaging. For the oral option, the listed supply is 30 days; the injection is described as a monthly vial. Neither description provides a reason to substitute one format for the other without discussing the prescription with the clinician.

Get an answer about any laboratory charges separately. A promise of free physician visits does not necessarily include a blood draw, an outside laboratory bill or supplies not named in the selected offer.

The renewal model matters

Strut labels the service as auto-refill and says customers may cancel at any time. Monthly delivery can simplify administration, but it also requires a clear cancellation process. Find out when a refill becomes noncancelable, whether the care team confirms a prescription change before dispatch and how to handle medication that remains unused.

It is particularly important to clarify what happens if the clinician switches the formulation. An existing injection renewal should not be assumed to stop simply because a patient asks about the lozenge. Obtain confirmation of any change in the active subscription.

Needle-free does not establish equivalent results

The lozenge offers a different administration route, which may be relevant to a person's preferences. However, using the same ingredient name does not establish equivalent absorption, clinical benefit or safety across products. The page's mechanism discussion and clinician quotation do not substitute for a direct comparison of the exact formulations.

Strut explicitly identifies the products as compounded and states that the FDA has not evaluated them for safety, effectiveness or quality. That disclosure is more useful than treating either format as an approved replacement for another growth-hormone treatment. Discuss the evidence and alternatives with the prescriber.

What to resolve before choosing a format

Ask for the dispensing pharmacy, formulation, supplied quantity and pharmacy-specific storage instructions. If travel or refrigeration affects your choice, request the actual product instructions rather than inferring convenience from the word “oral.” The provider's page advises refrigeration as directed by the pharmacy for both formats.

Strut is useful for readers who want to compare two delivery options within one care service. It should be shortlisted on that basis and on its disclosed service inclusions, while the medical decision remains separate. A completed comparison includes the selected format, first invoice, next refill date and the evidence relevant to that route.

Useful distinctions

  • Separate format-specific prices
  • Consultations and shipping included in stated price
  • Compounding disclosure is prominent

Limitations to weigh

  • Injection and lozenge cannot be assumed equivalent
  • Auto-refill cutoff requires confirmation
  • Laboratory costs not established

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. Strut Health: Sermorelin injection and oral lozenge Provider
  2. FDA: Understanding the Risks of Compounded Drugs Regulatory